Sulindac Tablet
Product Images NDC 0591-5660
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 0591-5660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of a medication called Sulindac in tablet form, with each tablet containing 150 MG of USP. The pharmacist is instructed to dispense the medication guide that comes with it to each patient. The medication guide can also be printed from the website tevausa.com/medguides. The dosage information and full prescribing information are available in the package insert. The tablets should be stored in a well-closed container with a child-resistant closure at 20° to 25°C (68°-77°F). The drug is manufactured in India by Watson Pharma Private Limited and is distributed by Teva Pharmaceuticals in Parsippany, NJ. A serialization coding area is also visible on the packaging.*
Image 3
The text explains medication details for Sulindac tablets and advises to print medication guides from Teva's website. Each tablet contains 200mg of Sulindac and should be supplied in a closed container with resistant closure. Dosage information is available in the package insert and prescribing information. The tablets should be stored at room temperature. Additionally, pharmacists should dispense medication guides to accompany the controlled substance for each patient. The manufacturer is Teva Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.